CClinicalTrials.gg
Status unknownNCT05391204H-ReproUpdated May 25, 2022

Reproducibility of Strength Testing and Functional Testing of the Hip for the Return to Sport of Patients Activated by a Femoroacetabular Impingement: Comparison Between a Group of Patients and a Group of Healthy Controls

An interventional study of Functional Tests in Femoroacetabular Impingement, sponsored by Ramsay Générale de Santé. Status unknown at 1 site in France. Open to participants aged 16 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-25.

Sponsored by Ramsay Générale de Santé · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Oct 2020, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
16 Years to 50 Years
Sex
All
01

Study summary

Reproducibility of strength testing and functional testing of the hip for the return to sport of patients activated by a femoroacetabular impingement: comparison between a group of patients and a group of healthy controls Femoroacetabular impingement is a disorder movement-related hip clinic, with bone abnormality at the joint coxo-femoral associated with a triad of symptoms, clinical signs and findings imagery. It represents premature contact symptomatic between the femur and the acetabulum. Currently, there is no consensus for determine when to return to sport securely after processing arthroscopy of a emoroacetabular impingement. Various clinical tests are used to assess the mobility or pain but no test studies specifically the level of recovery functional.

Read the detailed description

Reproducibility of strength testing and functional testing of the hip for the return to sport of patients activated by a femoroacetabular impingement: comparison between a group of patients and a group of healthy controls Femoroacetabular impingement is a disorder movement-related hip clinic, with bone abnormality at the joint coxo-femoral associated with a triad of symptoms, clinical signs and findings imagery. It represents premature contact symptomatic between the femur and the acetabulum. Currently, there is no consensus for determine when to return to sport securely after processing arthroscopy of a emoroacetabular impingement. Various clinical tests are used to assess the mobility or pain but no test studies specifically the level of recovery functional.

02

Conditions studied

  • Femoroacetabular Impingement

Keywords

  • femoroacetabular Impingement
  • Reproducibility of strength testing and functional testing
03

In context

Femoracetabular Impingement

108 studies on the registry are indexed under Femoracetabular Impingement; 35 are open to participants now.

This study's planned enrollment of 50 is below the median of 75 across 63 interventional studies indexed under Femoracetabular Impingement.

Browse Femoracetabular Impingement studies →

Lead sponsor

Ramsay Générale de Santé is the lead sponsor of 42 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Patients

  • Male or female aged 16 to 50
  • Occurrence of the injury requiring surgery during a sports activity
  • Hip arthroscopy
  • Surgery performed by surgeons from the Santy Orthopedic Center (Lyon)
  • Angle Alpha > 55°
  • Patient having signed an informed consent
  • Affiliated subject or beneficiary of a social Security

Control group

  • Male or female aged 16 to 50
  • Practicing a regular sporting activity In both groups
  • Patient having signed an informed consent
  • Affiliated subject or beneficiary of a social Security

Exclusion criteria

Exclusion Criteria:

Patient group

  • Contraindication of the surgeon
  • Present another pathology of the hip on the side of the operated limb or on the contralateral side

Control group

  • Declare a history of lower limb pain/injury in the last 12 months
  • Declare a history of orthopedic surgery on the lower limbs

In any case will be excluded Protected subject: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Healthy Volunteers

    To answer the question of reproducibility of the measurement (1st objective), half of the group control will carry out two handover of the battery of functional tests to a week apart.

    Other: Functional Tests

  • Experimental
    Patients Volunteers

    To answer the question of reproducibility of the measurement (1st objective), half the group patient will perform two examinations at two months apart.

    Other: Functional Tests

Interventions

  • OtherFunctional Tests

    Various physical exercices of inferior members

06

What researchers measure

Primary outcomes

  1. Reproducibility rate

    intra- and inter-session reproducibility

    Time frame: 8 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05391204
Lead sponsor
Ramsay Générale de Santé
Collaborators
Ramsay santé
Responsible party
Sponsor
First posted
May 25, 2022
Start date
Oct 20, 2020
Primary completion
Jan 31, 2023 (estimated)
Completion
Jan 31, 2023 (estimated)
Last update
May 25, 2022

Study contacts

JF ECTEN
Contact
jf.oudet@ecten.eu
0683346567
MH BARBA
Contact
mh.barba@ecten.eu
0664888704
Mathieu THAUNAT, Dr
principal investigator · Centre santy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion